During oocyte maturation and early embryo development, they act as energy substrates as well as precursors for prostaglandins and steroid hormones synthesis, which impact pregnancy maintenance (106, 107)
Available options include GLP-1 receptor agonists such as semaglutide (2.4 mg weekly dose) and the dual GLP-1/GIP receptor agonist tirzepatide
GLP-1, short for Glucagon-like peptide-1, is a hormone that enhances insulin secretion and suppresses glucagon release, slowing down digestion
Actual daily consumption of meal replacements will vary for every patient as recommended by the Physician
The clinical reasoning for pairing these peptides is to influence the inflammatory and immune response described in references on how inflammation and the immune response unfold in the body without the trade-offs people associate with long-term corticosteroids or NSAIDs
References Jzwiak M, Bauer M, Kamysz W, Kleczkowska P